ELECTRONIC CONTINUING EDUCATION FOR
SPECIALISTS IN POISON INFORMATION

Module II -  New FDA Actions

INTRODUCTION

Welcome to the American Association of Poison Control Center’s electronic continuing education program for Specialists in Poison Information.  This second fourteen-day module will provide a review of new Food and Drug Administration (FDA) actions including product label changes, drug withdrawals, and newly approved agents.  Questions in this module are derived from Internet versions of press releases, Internet versions of FDA Talk Papers, and other resources that are widely available to most Specialists in Poison Information.
 

LEARNING OBJECTIVES

Upon completion of this electronic continuing education module, the participant will be able to:

1. Describe the clinical relevance of press releases and FDA communications concerning newly approved agents.

2. Discuss the rationale for labeling changes and product withdrawals.

3. Apply knowledge of new FDA actions to clinical scenarios.
 

AUTHOR

Peter Ciancaglini, PharmD
 

REVIEW PANEL

Daniel Cobaugh, PharmD
Prashant Joshi, MD
Ruth Lawrence, MD
Christine Stork, PharmD
Desiree Voorhies, RN, MEd
Paul Wax, MD
 

References